Cargando…

Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo

PURPOSE: : Carrimycin is a newly synthesized macrolide antibiotic with good antibacterial effect. Exploratory experiments found its function in regulating cell physiology, proliferation and immunity, suggesting its potential anti-tumor capacity. The aim of this study is to investigate the anti-tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Si-yuan, Zhao, Tong-chao, Zhou, Zhi-hang, Ju, Wu-tong, Liu, Ying, Tan, Yi-ran, Zhu, Dong-wang, Zhang, Zhi-yuan, Zhong, Lai-ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985557/ https://www.ncbi.nlm.nih.gov/pubmed/33744726 http://dx.doi.org/10.1016/j.tranon.2021.101074

Ejemplares similares

Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
por: Jin, Yong, et al.
Publicado: (2021)

Anti-inflammatory effect and antihepatoma mechanism of carrimycin
por: Li, Xiu-Yan, et al.
Publicado: (2023)

Stathmin guides personalized therapy in oral squamous cell carcinoma
por: Ju, Wu‐tong, et al.
Publicado: (2020)

A Case of Multidrug-Resistant Klebsiella pneumoniae Treated with Carrimycin
por: Zhu, Wenjun, et al.
Publicado: (2023)

Mechanism of sensitivity to cisplatin, docetaxel, and 5‐fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression
por: Zhao, Tong‐Chao, et al.
Publicado: (2021)

In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma
por: Jia, Lihua, et al.
Publicado: (2017)

Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma
por: Ma, Jie, et al.
Publicado: (2018)

Overcoming chemotherapy resistance using pH-sensitive hollow MnO(2) nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma
por: Zhou, Zhi-hang, et al.
Publicado: (2021)

Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma
por: Ma, Hai-long, et al.
Publicado: (2017)

A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma
por: Ju, Wu-tong, et al.
Publicado: (2022)

The In Vitro and In Vivo Antitumor Effects of Clotrimazole on Oral Squamous Cell Carcinoma
por: Wang, Juan, et al.
Publicado: (2014)

Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2
por: Yan, Haiyan, et al.
Publicado: (2021)

High‐risk lymph node ratio predicts worse prognosis in patients with locally advanced oral cancer
por: Zhao, Tong‐Chao, et al.
Publicado: (2020)

Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosome biogenesis
por: Yu, LaYow C., et al.
Publicado: (2023)

Effects of insulin-like growth factor binding protein 3 on cell growth and tumorigenesis in oral squamous cell carcinoma
por: Xu, Hong-Yuan, et al.
Publicado: (2019)

Anti-oral Squamous Cell Carcinoma Effects of a Potent TAZ Inhibitor AR-42
por: Su, Lingyu, et al.
Publicado: (2020)

Candida albicans Enhances the Progression of Oral Squamous Cell Carcinoma In Vitro and In Vivo
por: Vadovics, Máté, et al.
Publicado: (2022)

In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma
por: Luo, Qingqiong, et al.
Publicado: (2012)

Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma
por: Ma, Jie, et al.
Publicado: (2015)

Pterostilbene inhibits lung squamous cell carcinoma growth in vitro and in vivo by inducing S phase arrest and apoptosis
por: Tan, Kok-Tong, et al.
Publicado: (2019)

Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo
por: Harada, Koji, et al.
Publicado: (2017)

Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma
por: Wang, Xiao-Long, et al.
Publicado: (2020)

Cathepsin K Is Present in Invasive Oral Tongue Squamous Cell Carcinoma In Vivo and In Vitro
por: Bitu, Carolina C., et al.
Publicado: (2013)

Celecoxib suppresses lipopolysaccharide-stimulated oral squamous cell carcinoma proliferation in vitro and in vivo
por: Yoshida, Hisato, et al.
Publicado: (2019)

Expression of Concern: The in vitro and in vivo antitumor effects of clotrimazole on oral squamous cell carcinoma
Publicado: (2020)

Possible Action of Olaparib for Preventing Invasion of Oral Squamous Cell Carcinoma In Vitro and In Vivo
por: Nakamura, Nanami, et al.
Publicado: (2022)

Evaluation of in vitro and in vivo personalized cancer treatment assays for oral squamous cell carcinoma
por: Wahbi, Wafa, et al.
Publicado: (2023)

CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma
por: REN, ZHEN-HU, et al.
Publicado: (2016)

Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
por: Wang, Xiao-Xia, et al.
Publicado: (2014)

In Vitro and in Vivo Anticancer Activity of Pardaxin against Proliferation and Growth of Oral Squamous Cell Carcinoma
por: Han, Yifan, et al.
Publicado: (2015)

Anticancer effects of valproic acid on oral squamous cell carcinoma via SUMOylation in vivo and in vitro
por: Sang, Zhijian, et al.
Publicado: (2016)

RFC4 promotes the progression and growth of Oral Tongue squamous cell carcinoma in vivo and vitro
por: Zhang, Jian, et al.
Publicado: (2021)

Heat Shock Proteins 70 Regulate Cell Motility and Invadopodia-Associated Proteins Expression in Oral Squamous Cell Carcinoma
por: Ding, Le-Xi, et al.
Publicado: (2022)

Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma
por: Wu, Zhi-Zhong, et al.
Publicado: (2020)

Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
por: Yang, Zhi-Min, et al.
Publicado: (2022)

The Anti-Proliferative and Apoptotic Effects of Rutaecarpine on Human Esophageal Squamous Cell Carcinoma Cell Line CE81T/VGH In Vitro and In Vivo
por: Wang, Li-Yu, et al.
Publicado: (2022)

Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo
por: Yasukawa, Masaaki, et al.
Publicado: (2016)

Prognosis and Nomogram Prediction for Patients with Oral Squamous Cell Carcinoma: A Cohort Study
por: Zhang, Xin-Yuan, et al.
Publicado: (2023)

Bioinformatic Analysis Reveals an Immune/Inflammatory-Related Risk Signature for Oral Cavity Squamous Cell Carcinoma
por: Bai, Shuang, et al.
Publicado: (2019)

Stromal-epithelial lactate shuttle induced by tumor-derived interleukin-1β promotes cell proliferation in oral squamous cell carcinoma
por: Wu, Jie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sh8e9uk50p1mmf7n71m5r5p7s0